Lanvin Group Holdings Limited (LANV)

NYSE: LANV · IEX Real-Time Price · USD
1.600
+0.010 (0.63%)
Apr 22, 2024, 12:00 AM EDT - Market open
0.63%
Market Cap 232.03M
Revenue (ttm) 478.19M
Net Income (ttm) -245.92M
Shares Out 145.02M
EPS (ttm) -2.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 520
Open 1.550
Previous Close 1.590
Day's Range 1.550 - 1.600
52-Week Range 1.270 - 6.000
Beta 0.04
Analysts Hold
Price Target 5.00 (+212.5%)
Earnings Date Apr 30, 2024

About LANV

Lanvin Group Holdings Limited operates as a couture house worldwide. The company offers ready-to-wear, made to measure, footwear, leather goods, costume jewelry, accessories, eyewear, and childrenswear under the Lanvin brand name; ready-to-wear, legwear, lingerie and beachwear, and accessories under the Wolford brand; footwear under the Sergio Rossi brand name; luxury womenswear, footwear, handbags, jewelry, and leather goods under the St. John brand; and leisurewear and formalwear under the Caruso brand name. The company was founded in 1889 an... [Read more]

Industry Luxury Goods
Founded 2015
Employees 3,487
Stock Exchange NYSE
Ticker Symbol LANV
Full Company Profile

Financial Performance

In 2022, LANV's revenue was 422.31 million, an increase of 36.75% compared to the previous year's 308.82 million. Losses were -218.29 million, 234.0% more than in 2021.

Financial numbers in EUR Financial Statements

Analyst Forecast

According to one analyst, the rating for LANV stock is "Hold" and the 12-month stock price forecast is $5.0.

Price Target
$5.0
(212.50% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Lanvin Group to Report 2023 Full-Year Audited Results on April 30, 2024

NEW YORK , April 22, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its audited results for the full-year 2023 on Tuesday, April 30, 2024. On ...

1 day ago - PRNewsWire

Analyses Find Patients With Polycythemia Vera (PV) Treated With BESREMi® (ropeginterferon alfa-2b) Had Increased Probability of Achieving Complete Hematologic Response

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expert...

22 days ago - Business Wire

Lanvin Group Resiliency was Key in 2023, Preliminary Revenues Up 1% Year-on-Year

Revenue of €426 million for FY2023, a 1% increase over FY 2022 Despite challenging conditions, Lanvin Group grew revenue by 8% in APAC Resiliency through creative transition at Lanvin brand helped imp...

2 months ago - PRNewsWire

Lanvin Group to Report 2023 Full-Year Preliminary Revenues on February 21, 2024

NEW YORK , Feb. 6, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today opened registration for its 2023 revenue results conference call. The Group will re...

2 months ago - PRNewsWire

Lanvin Group Holdings Limited to Hold Annual General Meeting on December 21, 2023

NEW YORK , Dec. 8, 2023 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV, the "Company" or "Lanvin Group"), a global luxury fashion group, today announced that it will hold its annual general...

4 months ago - PRNewsWire

Lanvin Group Announces New CEO

NEW YORK, Dec. 8, 2023 /PRNewswire/ -- The board of Lanvin Group (NYSE: LANV) today announced that Joann Cheng, the group's founding Chairman and Chief Executive Officer, has informed the board that s...

4 months ago - PRNewsWire

Lanvin Group Posts 6.4% Y-o-Y Revenue Growth In H1 2023

Group's Resilient Business Model Sees Growth Across All Channels and Geographies Group Revenue of €215 million for H1 2023, a 6.4% increase over H1 2022 Group Gross Profit Margin improved to 58.5% and...

8 months ago - PRNewsWire

Lanvin Group to Report 2023 First-Half Results on August 30, 2023

NEW YORK , Aug. 16, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its unaudited results for the first half of 2023 on Wednesday, August 30, 2...

8 months ago - PRNewsWire

Lanvin Group Posts Record Sales and Continued Margin Improvement in 2022. Revenues Up 37% Year-over-Year.

Revenues of €422 million for FY2022, a 37% increase over FY2021 Margin profile improvement with Group gross profit margin increasing to 56% and both contribution profit(1) and adjusted EBITDA margins ...

1 year ago - PRNewsWire

Lanvin Group to Report 2022 Full-Year Audited Results on April 20, 2023

NEW YORK , April 10, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will have its first audited results conference call since its public listing. The Group...

1 year ago - PRNewsWire

Lanvin's IPO Strengthens The Fall Winter 2023 Collection

Creative Director Bruno Sialelli's latest offering for the 134-year-old houses singled wearable merchandise with a high interest quotient.

1 year ago - Forbes

Lanvin Group Achieves Record Sales in 2022

P reliminary Revenues Up 38% Year-on-Year Revenues of €425 million for FY2022, a 38% increase on FY 2021, exceeding previous guidance (1) All portfolio brands delivered growth, with flagship brand Lan...

1 year ago - PRNewsWire

Lanvin Group to Report 2022 Full-Year Preliminary Revenues on February 17, 2023

NEW YORK , Feb. 10, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today opened registration for its first revenue results conference call since its public...

1 year ago - PRNewsWire

Clinical Review of ropeginterferon alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia Vera

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep exper...

1 year ago - Business Wire

Lanvin Group Plans to Announce 2022 Full-Year Preliminary Revenue Results on February 17, 2023; Announces Management Change

NEW YORK , Jan. 31, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today announced that it will report its unaudited full-year 2022 preliminary revenue res...

1 year ago - PRNewsWire

Lanvin Group Appoints Veteran Entertainment Executive, Ceci Kurzman as a New Independent Director; and Announces Changes in Composition of Board Committees

NEW YORK, Jan. 6, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today announced the appointment of Ms. Ceci Kurzman as a new independent director to its B...

1 year ago - PRNewsWire

Lanvin Group Debuts on NYSE under Ticker "LANV"

NEW YORK , Dec. 15, 2022 /PRNewswire/ --  Lanvin Group (the "Group"), a global luxury fashion group, and Primavera Capital Acquisition Corporation (NYSE: PV) ("PCAC"), today announced the completion o...

1 year ago - PRNewsWire

New Ropeginterferon alfa-2b Data Show Importance of Proactive Care Earlier in the Polycythemia Vera Patient Journey

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep exper...

1 year ago - Business Wire

Lanvin Group and Primavera Capital Acquisition Corporation Announce Updates in Relation to Business Combination

South Korea's Handsome Corporation will join Lanvin Group's roster of strategic investors Business combination agreement amended to remove closing condition in relation to minimum amount of cash Prima...

1 year ago - PRNewsWire

Lanvin Group and Primavera Capital Acquisition Corp. Announces Effectiveness of Registration Statement and Extraordinary General Meeting Date for Proposed Business Combination

SHANGHAI , Nov. 4, 2022 /PRNewswire/ -- November 4, 2022 – Lanvin Group (the "Group"), a global luxury fashion group, today announced that, the U.S. Securities and Exchange Commission ("SEC") has decl...

1 year ago - PRNewsWire